Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Michel

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Cell Reports Methods|May 9, 2023
TCR sequencing and cloning methods for repertoire analysis and isolation of tumor-reactive TCRsRaphael Genolet, Sara Bobisse, Johanna Chiffelle, et al.
Science Advances|June 11, 2025
Phage display enables machine learning discovery of cancer antigen-specific TCRsGiancarlo Croce, Rachid Lani, Delphine Tardivon, et al.
Nature Communications|March 17, 2018
Sensitive and frequent identification of high avidity neo-epitope specific CD8 <sup>+</sup> T cells in immunotherapy-naive ovarian cancerSara Bobisse, Raphael Genolet, Annalisa Roberti, et al.
Nature Biotechnology|June 25, 2024
Author Correction: Identification of clinically relevant T cell receptors for personalized T cell therapy using combinatorial algorithmsRémy Pétremand, Johanna Chiffelle, Sara Bobisse, et al.
Nature Biotechnology|May 7, 2024
Identification of clinically relevant T cell receptors for personalized T cell therapy using combinatorial algorithmsRémy Pétremand, Johanna Chiffelle, Sara Bobisse, et al.
Nature Cancer|September 22, 2023
A phase 1 trial of adoptive transfer of vaccine-primed autologous circulating T cells in ovarian cancerSara Bobisse, Valentina Bianchi, Janos L Tanyi, et al.
Science Translational Medicine|April 13, 2018
Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancerJanos L Tanyi, Sara Bobisse, Eran Ophir, et al.
Immunity|September 14, 2024
Tumor-reactive T cell clonotype dynamics underlying clinical response to TIL therapy in melanomaJohanna Chiffelle, David Barras, Rémy Pétremand, et al.
Nature Communications|June 6, 2023
Neoantigen-specific CD8 T cells with high structural avidity preferentially reside in and eliminate tumorsJulien Schmidt, Johanna Chiffelle, Marta A S Perez, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Cell Reports Methods|May 9, 2023
TCR sequencing and cloning methods for repertoire analysis and isolation of tumor-reactive TCRsRaphael Genolet, Sara Bobisse, Johanna Chiffelle, et al.
Science Advances|June 11, 2025
Phage display enables machine learning discovery of cancer antigen-specific TCRsGiancarlo Croce, Rachid Lani, Delphine Tardivon, et al.
Nature Communications|March 17, 2018
Sensitive and frequent identification of high avidity neo-epitope specific CD8 <sup>+</sup> T cells in immunotherapy-naive ovarian cancerSara Bobisse, Raphael Genolet, Annalisa Roberti, et al.
Nature Biotechnology|June 25, 2024
Author Correction: Identification of clinically relevant T cell receptors for personalized T cell therapy using combinatorial algorithmsRémy Pétremand, Johanna Chiffelle, Sara Bobisse, et al.
Nature Biotechnology|May 7, 2024
Identification of clinically relevant T cell receptors for personalized T cell therapy using combinatorial algorithmsRémy Pétremand, Johanna Chiffelle, Sara Bobisse, et al.
Nature Cancer|September 22, 2023
A phase 1 trial of adoptive transfer of vaccine-primed autologous circulating T cells in ovarian cancerSara Bobisse, Valentina Bianchi, Janos L Tanyi, et al.
Science Translational Medicine|April 13, 2018
Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancerJanos L Tanyi, Sara Bobisse, Eran Ophir, et al.
Immunity|September 14, 2024
Tumor-reactive T cell clonotype dynamics underlying clinical response to TIL therapy in melanomaJohanna Chiffelle, David Barras, Rémy Pétremand, et al.
Nature Communications|June 6, 2023
Neoantigen-specific CD8 T cells with high structural avidity preferentially reside in and eliminate tumorsJulien Schmidt, Johanna Chiffelle, Marta A S Perez, et al.
Pageof 6